Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001075309 | SCV001240927 | likely pathogenic | Retinal dystrophy | 2017-12-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001091897 | SCV001248168 | pathogenic | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001091897 | SCV002243407 | pathogenic | not provided | 2021-07-17 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 866921). This variant has been observed in individuals with autosomal dominant retinitis pigmentosa (PMID: 21618346, 33576794; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (ExAC no frequency). This sequence change replaces tyrosine with cysteine at codon 689 of the SNRNP200 protein (p.Tyr689Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. |
Institute for Clinical Genetics, |
RCV001091897 | SCV004026492 | likely pathogenic | not provided | 2022-05-24 | criteria provided, single submitter | clinical testing | PS4, PP3, PM2_SUP, PP1 |